Northwestern Mutual Wealth Management
PRTK

Northwestern Mutual Wealth Management’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio PRTK Stock Details PRTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-100
Closed -$254 – 3688
2023
Q1 		$254 Buy
+100
New +$198 ﹤0.01% 3170

Other funds holding PRTK

NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GAI
General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BC
Bruce & Co Chicago, Illinois $350M AUM 33.5% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return

Northwestern Mutual Wealth Management's PRTK Position: Q2 2023 in Review

Northwestern Mutual Wealth Management sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q2 2023, closing a stake of 100 shares — an estimated $254 sold.

Northwestern Mutual Wealth Management first reported a position in PRTK in Q1 2023 and held it in 1 quarter. The position peaked at $254 in Q1 2023. 66 funds tracked by Wall St. Rank hold PRTK as of Q2 2023.

  • Northwestern Mutual Wealth Management reported no remaining Paratek Pharmaceuticals, Inc. position as of Q2 2023 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 100 Paratek Pharmaceuticals, Inc. shares in Q2 2023, an estimated $254.
  • Northwestern Mutual Wealth Management first reported a position in Paratek Pharmaceuticals, Inc. in Q1 2023 and held it in 1 quarter.
  • Northwestern Mutual Wealth Management's Paratek Pharmaceuticals, Inc. position peaked at $254 in Q1 2023.
  • 66 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q2 2023.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2023, filed 14 Aug 2023.